News about Market

Pfizer to acquire Trillium Therapeutics

Pfizer and Trillium Therapeutics yesterday announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer. Under the terms of the agreement

Market | 24/08/2021 | By Darshana |  333

NPPA caps trade margin of 42 anti-cancer medicines, MRP of 562 brands gets reduced up to 90%

The National Pharmaceutical Pricing Authority (NPPA) has put a cap on trade margin of 42 select non-scheduled anti-cancer medicines under the "Trade Margin Rationalization (TMR)"

Market | 11/08/2021 | By Darshana |  278

DCGI classifies 51 medical devices related to respiratory health under rules

The Drugs Controller General (India) has classified 51 medical devices pertaining to respiratory treatments under the provisions of Medical Devices Rules, 2017, the rule formed to regulate them with respect to the import, manufacture, sale and distribution, and clinical investigation

Market | 10/08/2021 | By Darshana |  204

Sanofi to acquire clinical-stage mRNA therapeutics company, Translate Bio for US$ 3.2 billion

As part of Sanofi's endeavor to accelerate the application of messenger RNA (mRNA) to develop therapeutics and vaccines, the company has entered into a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutics company

Market | 04/08/2021 | By Darshana |  227

Oximeters, BP machines and 3 other devices to get cheaper as trade margins capped at 70%

The National Pharmaceutical Pricing Authority has capped trade margins at 70 percent for pulse oximeter, blood pressure monitoring machine, nebulizer, digital thermometer and glucometer. The revised prices come into effect from July 20.

Market | 14/07/2021 | By Darshana |  237

Redcliffe Lifetech introduces mucormycosis multiplex RT-PCR test to detect DNA of Mucorales species

Redcliffe Lifetech, a leading molecular diagnostics company, has introduced a non-invasive (serum/fluid) RT-PCR test to detect the DNA of Mucorales species. As a part of the diagnostic process, BAL samples will be used to directly detect the infection, with sample-to-result collection in less than 24 hours

Market | 03/06/2021 | By Darshana |  307

UK MHRA approves one-dose Janssen Covid-19 vaccine

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted regulatory approval for the Janssen's Covid-19 vaccine. This is the fourth Covid-19 vaccine to be authorised by the UK's independent regulator and is the first to be approved for protection against Covid-19 with a single dose

Market | 31/05/2021 | By Darshana |  285

LANXESS plans to expand capacity for Oxone monopersulfate - a main active ingredient for disinfectants

Due to the continuous strong demand for disinfectants, specialty chemicals company LANXESS is planning to expand its production capacity for Oxone monopersulfate by around 50 percent. To this end, the company intends to invest a lower double-digit million euro sum in its production facility in Memphis, USA

Market | 25/09/2020 | By Hemant |  441

FDA Proposes New Rule on Reporting RequirementUnder Right to Try Act

Today, the U.S. Food and Drug Administration published the proposed rule, Annual Summary Reporting Requirements Under the Right to Try Act, that when finalized, will implement a statutory requirement for sponsors and manufacturers to provide annual summary to the FDA for any eligible investigational drug they provide to eligible patients under Try Act

Market | 27/07/2020 | By Darshana |  591

FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next generation sequence technology

Market | 11/06/2020 | By Darshana |  807